Three former employees of large pharmas, including Novo and Sanofi, share how they were let go. While they appreciated some ...
"The turnaround has not happened. We still have a lot to do," Mittal told Moneycontrol in an interview, even as Syngene ...
Trade Brains on MSN
OneSource Q2: Revenue up 37% and EBITDA up 53% as new drug-device capacity starts paying off
India, Oct. 27 -- Big drug companies no longer want to make everything themselves. Injectable pens, biologics and complex ...
Cambrex, a global contract development and manufacturing organization (CDMO), has broken ground on a $120 million expansion ...
VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but ...
Akums Drugs and Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2026. For the second quarter, the company reported sales was INR 13,423.87 ...
Hanmi Pharmaceutical surpassed KRW 1.2 trillion in cumulative revenue for the first three quarters of this year, boosted by ...
As the Press Democrat first reported, DesigneRx notified the state in July that it wanted to end manufacturing at the Allison ...
Between the large CDMOs and specialty suppliers, there exists a gap where medtech organizations need a sophisticated ...
A year ago the market was expensive and the news was good. Today valuations are reasonable and the news is bad, says Manoj ...
With India stepping up its ambitions to strengthen its position in the global pharmaceutical manufacturing landscape, CPHI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results